29 January 2020 – London The updated Primary Care online Symptom Assessment aligns with Public Health England to help limit potential spread
Doctorlink, the UK’s leading online Symptom Assessment provider to the NHS, has updated its Symptom Assessment algorithms in the Doctorlink app, used by almost 1,000 surgeries across the UK, to identify and triage patients with risk factors for Coronavirus 2019-nCoV.
Patients using the app with flu like symptoms including fever, fatigue, sore throat, dry cough, breathing difficulties will be asked additional questions regarding their own travel or exposure to individuals that have been to affected areas.
Patients indicating risk factors for the virus will be advised by the symptom assessment platform to self-isolate and call the NHS-111 service, in line with Public Health England recommendations.
The app’s algorithms will be continually updated in line with government guidance as more information is determined about coronavirus 2019-nCoV and its spread.
Dr Ben Littlewood-Hillsdon, Chief Medical Officer at Doctorlink, commented: “Doctorlink has taken this preventative measure to support current government lead action to monitor and limit the spread should coronavirus 2019-nCoV reach the UK. We provide a digital front door for thousands of patients across the country and as such, see it as critical to support NHS clinicians and provide the right information to inform and reassure patients.
“The changes we’ve made are a perfect example of the value we provide to primary care by assessing patients for a potential diagnosis and routing them to the correct health service, particularly when there are changes in disease patterns that can risk a wide population. We’ll be continuing to update our algorithms in light of new discoveries and guidance about the virus in order to best support government advice.”
The Doctorlink platform is an online Symptom Assessment platform – whose algorithms have been developed by a team of expert clinicians over the last 18 years – that are so advanced that it is classified as a Class 1 Medical Equipment device and whose outcomes are sufficiently accurate as to be fully indemnified enabling the technology to be selected by one of the world’s most trusted health services the NHS.
For more information: https://gov.uk/coronavirus